AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 161 filers reported holding AKERO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $366,961 | +1543.4% | 15,642 | +1669.5% | 0.01% | +500.0% |
Q1 2024 | $22,330 | -75.8% | 884 | -77.6% | 0.00% | 0.0% |
Q4 2023 | $92,093 | +74.1% | 3,944 | +277.1% | 0.00% | -50.0% |
Q3 2023 | $52,907 | -43.3% | 1,046 | -47.6% | 0.00% | -33.3% |
Q2 2023 | $93,287 | +62091.3% | 1,998 | -49.2% | 0.00% | -40.0% |
Q1 2023 | $150 | +29.3% | 3,935 | +84.5% | 0.01% | 0.0% |
Q4 2022 | $116 | -99.7% | 2,133 | +106.9% | 0.01% | +400.0% |
Q3 2022 | $35,000 | -54.5% | 1,031 | -87.4% | 0.00% | -50.0% |
Q2 2022 | $77,000 | -76.5% | 8,167 | -64.6% | 0.00% | -33.3% |
Q1 2022 | $328,000 | +786.5% | 23,058 | +1215.3% | 0.00% | +200.0% |
Q4 2021 | $37,000 | -7.5% | 1,753 | -2.1% | 0.00% | 0.0% |
Q3 2021 | $40,000 | -41.2% | 1,791 | -34.9% | 0.00% | -50.0% |
Q2 2021 | $68,000 | +161.5% | 2,752 | +211.3% | 0.00% | – |
Q1 2021 | $26,000 | -73.5% | 884 | -76.8% | 0.00% | -100.0% |
Q4 2020 | $98,000 | +100.0% | 3,806 | +141.2% | 0.00% | +200.0% |
Q3 2020 | $49,000 | +28.9% | 1,578 | +2.3% | 0.00% | -50.0% |
Q2 2020 | $38,000 | +171.4% | 1,542 | +126.1% | 0.00% | +100.0% |
Q1 2020 | $14,000 | -79.4% | 682 | -77.6% | 0.00% | -83.3% |
Q4 2019 | $68,000 | +161.5% | 3,049 | +120.8% | 0.01% | +200.0% |
Q2 2019 | $26,000 | – | 1,381 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 423,849 | $9,943,498 | 11.19% |
Propel Bio Management, LLC | 327,752 | $7,689,062 | 4.99% |
GENERAL ATLANTIC, L.P. | 5,233,989 | $122,789,382 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 625,087 | $14,664,541 | 3.46% |
Yiheng Capital Management, L.P. | 1,434,179 | $33,645,839 | 2.71% |
Redmile Group, LLC | 1,614,473 | $37,875,537 | 2.29% |
Boxer Capital, LLC | 1,676,733 | $39,336,156 | 2.07% |
RTW INVESTMENTS, LP | 5,431,985 | $127,434,368 | 1.97% |
Logos Global Management LP | 800,000 | $18,768,000 | 1.52% |
MPM BioImpact LLC | 385,990 | $9,055,325 | 1.41% |